Moderate caffeinated coffee consumption (2 to 3 cups/day) was associated with an 18% reduction in incident dementia risk compared to non-consumers.
Similar neuroprotective benefits were observed for tea consumption (1 to 2 cups/day), while decaffeinated coffee showed no significant association with cognitive outcomes.
The study, spanning over 40 years of follow-up, also linked higher caffeine intake to lower prevalence of subjective cognitive decline and improved objective cognitive scores.
Dose-response analysis revealed a non-linear relationship, suggesting that moderate intake provides the most pronounced benefit for brain health.
Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
